Articles

Search all PharmacoEconomics - Open articles

Filter by

Volume:

Sort by

Date published:

New to old Old to new

Showing 1-50 of 492 articles

Correction: NICE’s Pathways Pilot: Pursuing Good Decision Making in Difficult Circumstances
Dawn Lee
Darren Burns
Ed Wilson
Correction Open access 05 June 2024
Budget Impact Analysis of Olaparib in Combination with Bevacizumab for Maintenance Therapy for Ovarian Cancer in Argentina
Carlos Rojas-Roque
Constanza Silvestrini
Natalia Espinola
Original Research Article Open access 03 June 2024
Public Health Impact and Cost-Effectiveness Analysis of 4-Component Meningococcal Serotype B Vaccination for Infants in France
Gérard de Pouvourville
Manon Breau-Brunel
Céline Pribil
Original Research Article Open access 23 May 2024
Mapping Payment and Pricing Schemes for Health Innovation: Protocol of a Scoping Literature Review
Vittoria Ardito
Ludovico Cavallaro
Oriana Ciani
Protocol Open access 21 May 2024
Public Preference for Financing Preventive Vaccines in Health Shocks: The Case of COVID-19 Vaccines in a Middle-Income Country
Najmeh Moradi
Leila Zarei
Kamran Bagheri Lankarani
Original Research Article Open access 18 May 2024
Correction: Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension
Rod S. Taylor
Anthony Bentley
Roland E. Schmieder
Correction Open access 08 May 2024
Cancer-Specific Health Utilities: Evaluation of Core Measurement Properties of the EORTC QLU-C10D in Lung Cancer Patients—Data from Four Multicentre LUX-Lung Trials, Applying Six Country Tariffs
Micha J. Pilz
Simone Seyringer
the EORTC Quality of Life Group
Original Research Article Open access 02 May 2024
Whither Decision-Analytic Modelling-Based Economic Evaluation for Health Care Decision Making?
Rachael Maree Hunter
Matthew Franklin
Editorial Open access 25 April 2024
Evaluating the Long-Term Cost-Effectiveness of the English NHS Diabetes Prevention Programme using a Markov Model
Emma McManus
Original Research Article Open access 20 April 2024
Part of 1 collection:

Open-Source Models
Cost of Care for Non-communicable Diseases: Which Types of Healthcare Providers are the Most Economical in India’s Chhattisgarh State?
Samir Garg
Narayan Tripathi
Kirtti Kumar Bebarta
Original Research Article Open access 17 April 2024
NICE’s Pathways Pilot: Pursuing Good Decision Making in Difficult Circumstances
Dawn Lee
Darren Burns
Ed Wilson
Editorial Open access 13 April 2024
Part of 1 collection:

Open-Source Models
Updated Public Health Impact and Cost Effectiveness of Recombinant Zoster Vaccine in Canadian Adults Aged 50 Years and Older
Sydney George
Justin Carrico
Nikolaos Giannelos
Original Research Article Open access 11 April 2024 Pages: 481 - 492
Behind the Scenes: A Qualitative Investigation of Interviewers' Performance in EQ-5D Valuation Studies
Carlotta Varriale
Giovanni Andrulli
Aureliano Paolo Finch
Original Research Article Open access 09 April 2024 Pages: 389 - 401
Can Cyprus Afford Luspatercept? A Budget Impact Analysis of the Reimbursement of Luspatercept for the Management of Thalassaemia in Cyprus
Olga Pitsillidou
Panagiotis Petrou
M. J. Postma
Original Research Article Open access 04 April 2024 Pages: 471 - 480
A Canadian Simulation Model for Major Depressive Disorder: Study Protocol
Shahzad Ghanbarian
Gavin W. K. Wong
Stirling Bryan
Protocol Open access 26 March 2024 Pages: 493 - 505
Part of 1 collection:

Protocols
Cost-Effectiveness Analysis of Etranacogene Dezaparvovec Versus Extended Half-Life Prophylaxis for Moderate-to-Severe Haemophilia B in Germany
Niklaus Meier
Hendrik Fuchs
Matthias Schwenkglenks
Original Research Paper Open access 23 March 2024 Pages: 373 - 387
Part of 1 collection:

Open-Source Models
A Systematic Review of Health-Related Quality of Life in Women with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab
Sudewi Mukaromah Khoirunnisa
Fithria Dyah Ayu Suryanegara
Maarten Jacobus Postma
Systematic Review Open access 15 March 2024
Identification and prioritisation of items for a draft participant-reported questionnaire to measure use of social care, informal care, aids and adaptations
Kirsty M. Garfield
Gail A. Thornton
Joanna C. Thorn
Original Research Article Open access 07 March 2024 Pages: 431 - 443
A Cost-Utility Analysis of Add-On Cannabidiol Versus Usual Care Alone for the Treatment of Seizures Associated with Tuberous Sclerosis Complex in England and Wales
Colin Burke
Catriona Crossan
Sally Bowditch
Original Research Article Open access 05 March 2024
Cost-Effectiveness of Faricimab in the Treatment of Diabetic Macular Oedema (DMO): A UK Analysis
Christian Bührer
Thomas Paling
Marloes Bagijn
Original Research Article Open access 04 March 2024 Pages: 445 - 457
Cost-Effectiveness of Routine Monitoring of Long-Term Conditions in Primary Care: Informing Decision Modelling with a Systematic Review in Hypertension, Type 2 Diabetes and Chronic Kidney Disease
Syed G. Mohiuddin
Mary E. Ward
Howard H. Z. Thom
Systematic Review Open access 23 February 2024 Pages: 359 - 371
Correction: From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy
Elvio Emanuele Rossini
Carlotta Galeone
Claudio Jommi
Correction Open access 12 February 2024 Pages: 345 - 345
Artificial Intelligence to Automate Network Meta-Analyses: Four Case Studies to Evaluate the Potential Application of Large Language Models
Tim Reason
Emma Benbow
Bill Malcolm
Original Research Article Open access 10 February 2024 Pages: 205 - 220
Artificial Intelligence to Automate Health Economic Modelling: A Case Study to Evaluate the Potential Application of Large Language Models
Tim Reason
William Rawlinson
Sven Klijn
Original Research Article Open access 10 February 2024 Pages: 191 - 203
Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension
Rod S. Taylor
Anthony Bentley
Roland E. Schmieder
Original Research Article Open access 30 January 2024
Health Economic Evaluations of Hemochromatosis Screening and Treatment: A Systematic Review
Malvina Hoxha
Visar Malaj
Bruno Zappacosta
Systematic Review Open access 27 January 2024 Pages: 147 - 170
An Economic Evaluation of a Streamlined Day-Case Atrial Fibrillation Ablation Protocol and Conventional Cryoballoon Ablation versus Antiarrhythmic Drugs in a UK Paroxysmal Atrial Fibrillation Population
Joe W. E. Moss
Derick Todd
Prapa Kanagaratnam
Original Research Article Open access 20 January 2024 Pages: 417 - 429
Cost-Effectiveness Analysis of Abrocitinib Compared with Other Systemic Treatments for Severe Atopic Dermatitis in Spain
Rosa María Romero Jiménez
Pedro Herranz Pinto
Francisco José Rebollo Laserna
Original Research Article Open access 18 January 2024 Pages: 291 - 302
Cost-Effectiveness Analysis of Digital Breast Tomosynthesis Added to Synthetic Mammography in Breast Cancer Screening in Brazil
Henrique Lima Couto
Ludmila Peres Gargano
Fernando Zanghelini
Original Research Article Open access 18 January 2024 Pages: 403 - 416
Introducing Open Science in Teaching Health Economic Modelling
Xavier G. L. V. Pouwels
Hendrik Koffijberg
Practical Application Open access 18 January 2024 Pages: 347 - 357
Part of 1 collection:

Open-Source Models
From Indication-Based Pricing to Blended Approach: Evidence on the Price and Reimbursement Negotiation in Italy
Elvio Emanuele Rossini
Carlotta Galeone
Claudio Jommi
Original Research Article Open access 16 January 2024 Pages: 251 - 261
A Systematic Literature Review of Health-Related Quality of Life Outcomes and Associated Utility Values in Relapsed and/or Refractory Large B Cell Lymphoma
Fei Fei Liu
Meaghan Bartlett
Samantha Craigie
Systematic Review Open access 10 January 2024 Pages: 171 - 190
Health-Related Quality of Life and Economic Burden Among Hospitalized Children with Hand, Foot, and Mouth Disease: A Multiregional Study in China
Ting Zhou
Hongfei Hu
Pei Wang
Original Research Article Open access 09 January 2024 Pages: 459 - 469
Health State Utilities Associated with False-Positive Cancer Screening Results
Louis S. Matza
Timothy A. Howell
Karen C. Chung
Original Research Article Open access 08 January 2024 Pages: 263 - 276
Cost-Utility Analysis of Total Ankle Replacement Compared with Ankle Arthrodesis for Patients Aged 50–85 Years with End-Stage Ankle Osteoarthritis: The TARVA Study
Andrew J. Goldberg
Ekaterina Bordea
the TARVA Study Group
Original Research Article Open access 08 January 2024 Pages: 235 - 249
Understanding the Natural History of Chronic Hepatitis D: Proposal of a Model for Cost-Effectiveness Studies
Ankita Kaushik
Geoffrey Dusheiko
Robert J. Wong
Original Research Article Open access 03 January 2024 Pages: 333 - 343
Acknowledgement to Referees

Acknowledgement to Referees Open access 20 December 2023 Pages: 1 - 3
Economic Evaluation of a Personalized Nutrition Plan Based on Omic Sciences Versus a General Nutrition Plan in Adults with Overweight and Obesity: A Modeling Study Based on Trial Data in Denmark
Milanne Maria Johanna Galekop
Carin Uyl-de Groot
William Ken Redekop
Original Research Article Open access 19 December 2023 Pages: 313 - 331
The Efficiency of Increased HCV Testing and Treatment Strategies in Spain to Achieve Elimination Goals
Jose Luis Calleja
Jaime Espin
Adam Igloi-Nagy
Original Research Article Open access 15 December 2023 Pages: 221 - 233
The Acceptance of Indirect Treatment Comparison Methods in Oncology by Health Technology Assessment Agencies in England, France, Germany, Italy, and Spain
Bérengère Macabeo
Théophile Rotrou
Philippe Laramée
Original Research Article Open access 14 December 2023 Pages: 5 - 18
Cost-Effectiveness Analysis of Adjuvant Olaparib Versus Watch and Wait in the Treatment of Germline BRCA1/2-Mutated, High-Risk, HER2-Negative Early Breast Cancer in Sweden
Maria Polyzoi
Mattias Ekman
Robert Hettle
Original Research Article Open access 13 December 2023 Pages: 277 - 289
An Analysis of Uncertainties and Data Collection Agreements in the Cancer Drugs Fund
Laura A. Trigg
Maxwell S. Barnish
Caroline Farmer
Original Research Article Open access 12 December 2023 Pages: 303 - 311
United States Value Set for the Functional Assessment of Cancer Therapy-General Eight Dimensions (FACT-8D), a Cancer-Specific Preference-Based Quality of Life Instrument
Madeleine T. King
D. A. Revicki
the MAUCa Consortium
Original Research Article Open access 07 December 2023 Pages: 49 - 63
Correction: Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15
Marty Chaplin
Rebecca Bresnahan
Pinki Munot
Correction Open access 05 December 2023 Pages: 1015 - 1015
Early Cost-Effectiveness Analysis of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer Patients with Limited Peritoneal Carcinomatosis
Joost G. E. Verbeek
Karen van der Sluis
Valesca P. Retèl
Original Research Article Open access 30 November 2023 Pages: 119 - 131
Developing a Natural History Model for Duchenne Muscular Dystrophy
Jonathan Broomfield
M. Hill
Project HERCULES, the Cooperative International Neuromuscular Research Group investigators, Duchenne Regulatory Science Consortium members
Original Research Article Open access 29 November 2023 Pages: 79 - 89
Cost-Effectiveness of Neoadjuvant Pembrolizumab plus Chemotherapy Followed by Adjuvant Pembrolizumab in Patients with High-Risk, Early-Stage, Triple-Negative Breast Cancer in Switzerland
Andrea Favre-Bulle
Min Huang
Arjun Bhadhuri
Original Research Article Open access 24 November 2023 Pages: 91 - 101
Preferences for Living Arrangements in Dementia: A Discrete Choice Experiment
Christian Speckemeier
Carina Abels
Silke Neusser
Original Research Article Open access 23 November 2023 Pages: 65 - 78
Economic Burden of Delayed Diagnosis in Patients with Pulmonary Arterial Hypertension (PAH)
Hilary M. DuBrock
Hayley D. Germack
Robert P. Frantz
Original Research Article Open access 18 November 2023 Pages: 133 - 146
Cost of Patients with Alzheimer’s Disease in Spain According to Disease Severity
Laura Gómez Maldonado
Ricardo de Mora-Figueroa
María Merino
Original Research Article Open access 15 November 2023 Pages: 103 - 114

1
2
…
10
Next page